Two Sigma Investments, LP Century Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 66,797 shares of IPSC stock, worth $51,433. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,797Holding current value
$51,433% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding IPSC
# of Institutions
72Shares Held
37.4MCall Options Held
8.7KPut Options Held
10.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$4.17 Million1.48% of portfolio
-
Casdin Capital, LLC New York, NY5.19MShares$4 Million0.45% of portfolio
-
Vr Adviser, LLC New York, NY3.96MShares$3.05 Million0.66% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$2.23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.83 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $45.3M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...